Second bivalent COVID-19 booster vaccine from Moderna (Spikevax) authorised by UK medicines regulator
This adapted COVID-19 vaccine targets both the original coronavirus (SARS-CoV-2) and the Omicron BA.4 and BA.5 sub-variants.
Month: February 2023
Regulatory approval of Spikevax bivalent Original/Omicron booster vaccines
Information for healthcare professionals and the public on Moderna’s bivalent vaccines. Information on the original Spikevax COVID-19 vaccine can found on a separate page (link below)
Millions of people get boosted against Covid
Nearly 17.5 million eligible people received their Covid autumn booster jab, with tens of thousands coming forward in the final week of the programme.
Thousands give their views on how COVID-19 Pandemic should be remembered in the UK
The UK Commission on Covid Commemoration is now considering all responses and final recommendations will be put to Government in Spring.